Munch-a-Biotech Today Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Munch-a-Biotech Today

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: aknahow who wrote (797)	1/14/2000 9:24:00 AM
From: Biomaven	Read Replies (2) of 3158

george, I don't view the mega-mergers as good news for biotechs. The list of possible partners shrink, and the weaker projects at the combined companies tend to get culled. Most biotechs are no longer cheap, and so this will also dampen mergers. The one area that may boom is if the larger biotechs with high stock prices (like AMGN and the booming genomics companies like CRA) go shopping with their highly-valued stock as currency. I have to believe that BGEN must be seriously out looking at this point as well. There are a few biotechs that still look cheap and munchable - GLIA, GELX, PGNS and maybe LIPO come to mind as depressed biotechs with real products and decent prospects. (I currently own a bunch of GLIA and a little GELX and PGNS). Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next